Back to results
US 2023/0404995 A1Published application
Compositions and methods for treating pulmonary fibrosis
AssigneePulmosim Therapeutics LLC
InventorVivek GUPTA
Life of this patent
Estimating the term…
Abstract
The present disclosure relates generally to compositions and methods for preventing, ameliorating or treating pulmonary fibrosis and/or reducing the severity of one or more risk factors, signs, or symptoms associated with pulmonary fibrosis.
Claims14
A method for treating or preventing idiopathic pulmonary fibrosis (IPF) in a subject in need thereof, comprising administering to the subject a therapeutically effective amount of quinacrine or a pharmaceutically acceptable salt thereof.
(canceled)
Dependencies are inferred from the claim text.